Evidence map›Paper›PMID 9893040›Full record

ArticleImmunology1998

Inhibition of interleukin-2 by a Gram-positive bacterium, Streptococcus mutans.

L M Plitnick, J A Banas, D M Jelley-Gibbs, J O'neil, T Christian, S P Mudzinski, E J Gosselin

Abstract read
In one paragraph

Article in Immunology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Induction of cytokines by glucosyltransferases of streptococcus mutans.Clinical and diagnostic laboratory immunology · 2002
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

L M PlitnickDepartment of Microbiology, Cellular Immunology Laboratory, Albany Medical College, Albany, NY 12208, USA.
J A Banas
D M Jelley-Gibbs
J O'neil
T Christian
S P Mudzinski
E J Gosselin

Funding

GLUCAN BINDING PROTEINS OF ORAL STREPTOCOCCIR01DE010058 · NIDCR · UNIVERSITY OF IOWA · PI BANAS, JEFFREY A · 1999 to 2007
$1.8M
HUMAN FC RECEPTOR--ENHANCED ANTIGEN PRESENTATION DEFINEDR29AI035327 · NIAID · ALBANY MEDICAL COLLEGE · PI GOSSELIN, EDMUND J · 1993 to 1997
–
GLUCAN BINDING PROTEINS OF ORAL STREPTOCOCIR29DE010058 · NIDCR · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI BANAS, JEFFREY A · 1992 to 1996
–
NIAID NIH HHS AI35327NIDCR NIH HHS DE10058
6 · The paper itself

Abstract

Generation of an effective cellular immune response is key to the successful development of both humoral and cellular immune defences against most pathogens. However, while the type of cellular immune response elicited by any given pathogen is dictated by the entire array of antigens and molecules which comprise that pathogen, most studies of human immune responses to bacterial pathogens tend to focus on selected antigens. This is a result, in part, of a desire to find those antigens that will generate a desired immune response, as well as limited technology for monitoring the complex array of responses generated by an intact organism. Utilizing Streptococcus mutans as a model Gram-positive organism, a novel flow cytometric assay that permits the identification of individual cells within a responding population, and highly sensitive cytokine assays, we show for the first time that CD8 T cells and natural killer (NK) cells comprise a significant component of the response to this organism in humans. This is despite the fact that CD8 T cells are traditionally thought to respond to endogenously derived antigens only. In addition, we provide the first evidence that a Gram-positive organism can actively inhibit interleukin-2 (IL-2), an important autocrine growth factor for T cells. The latter observation could represent an additional mechanism by which Gram-positive organisms evade host defences.

Indexed as

AdultCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DivisionCells, CulturedDepression, ChemicalFlow CytometryHumansInterleukin-2Killer Cells, NaturalMonocytesStreptococcus mutansT-LymphocytesInterleukin-2

Identifiers

PMID9893040
PMCPMC1364347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.